Why McKesson (MCK) Is a Top Value Stock for the Long-Term
Nike Earnings, McCormick & Co. CEO: Market Domination Overtime
Sector Update: Consumer Stocks Mixed in Late Afternoon Trading
Consumer stocks were mixed late Thursday afternoon with the Consumer Staples Select Sector SPDR Fund (XLP) falling 0.6% and the Consumer Discretionary Select Sector SPDR Fund (XLY) rising 0.5%. In cor
Here Is What to Know Beyond Why McKesson Corporation (MCK) Is a Trending Stock
Can McKesson (MCK) Steadily Compound Earnings?
McKesson (MCK) Stock Slides as Market Rises: Facts to Know Before You Trade
McKesson Corporation Announces First Quarter Fiscal 2025 Earnings Release Date
McKesson Corporation (NYSE:MCK) will release its first quarter fiscal 2025 financial results after market close on Wednesday, August 7, 2024. The company will host a live webcast of the earnings conference call for
McKesson IdeaShare Ignites and Inspires Independent Community Pharmacies
Dreier Pharmacy Named 2024 Health Mart Pharmacy of the Year New McKesson Amplify Initiative Supports State Pharmacy Association Advocacy Efforts This week, McKesson Corporation, Health Mart, and Health Mart Atlas,
BofA Securities Maintains McKesson(MCK.US) With Buy Rating, Maintains Target Price $670
BofA Securities analyst Allen Lutz maintains $McKesson(MCK.US)$ with a buy rating, and maintains the target price at $670.According to TipRanks data, the analyst has a success rate of 53.3% and a tota
McKesson Is Maintained at Buy by B of A Securities
McKesson Is Maintained at Buy by B of A Securities
BofA Securities Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $670
BofA Securities analyst Allen Lutz maintains $McKesson(MCK.US)$ with a buy rating, and adjusts the target price from $590 to $670.According to TipRanks data, the analyst has a success rate of 53.3% an
Express News | Mckesson Corp : BofA Global Research Raises Price Objective to $670 From $590
Independent Pharmacy Cooperative (IPC) and McKesson Forge New Supply Agreement
Independent Pharmacy Cooperative (IPC), a leading group purchasing organization of community pharmacies, is pleased to announce a new supply...
Outcomes Showcased at McKesson IdeaShare 2024
Outcomes, a leader in integrated pharmacy workflow and patient engagement solutions, announced that it will feature a new prescription counting solution, Pill Count, at McKesson ideaShare. By leveraging AI and machine
McKesson Is Maintained at Buy by Argus Research
McKesson Is Maintained at Buy by Argus Research
McKesson Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 06/24/2024 10.74% Argus Research $570 → $670 Maintains Buy 05/09/2024 -9.92% Deutsche Bank $547 → $545 Mai
Argus Research Maintains McKesson(MCK.US) With Buy Rating, Raises Target Price to $670
Argus Research analyst David Toung maintains $McKesson(MCK.US)$ with a buy rating, and adjusts the target price from $570 to $670.According to TipRanks data, the analyst has a success rate of 63.1% an
Argus Adjusts Price Target on McKesson to $670 From $570
McKesson (MCK) has an average outperform rating and a price target range of $460 to $679, according to analysts polled by Capital IQ. Price: 605.75, Change: +2.67, Percent Change: +0.44
McKesson (MCK) Reaches 52-Week High: What's Aiding the Stock?
McKesson (MCK) Increases Despite Market Slip: Here's What You Need to Know